A detailed history of Opal Wealth Advisors, LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Opal Wealth Advisors, LLC holds 191 shares of TMDX stock, worth $21,869. This represents 0.01% of its overall portfolio holdings.

Number of Shares
191
Holding current value
$21,869
% of portfolio
0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 14, 2025

BUY
$67.67 - $143.04 $12,924 - $27,320
191 New
191 $25,000
Q2 2024

Jul 12, 2024

BUY
$72.62 - $150.62 $3,050 - $6,326
42 Added 45.16%
135 $20,000
Q1 2024

Apr 11, 2024

BUY
$70.86 - $89.93 $6,589 - $8,363
93 New
93 $6,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $3.64B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Opal Wealth Advisors, LLC Portfolio

Follow Opal Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opal Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Opal Wealth Advisors, LLC with notifications on news.